Tizanidine-1 (Tizanidine 1)
Tizanidine Tablet
Product Images NDC 71335-3016
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 71335-3016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tizanidine-2 (Tizanidine 2)
This is not-readable.*
Tizanidine-3 (Tizanidine 3)
Tizanidine-4 (Tizanidine 4)
The text describes the improvement in Ashworth Score during a study, showing the mean dose of 26.8 mg at the end of titration (Study Week 3) and the endpoint by the Last Observation Carried Forward method at the end of maintenance (Study Week 7).*
Label (Lbl713353016)
This is a medication package insert for Tizanidine Tablets with each tablet containing 4.576 mg of Tizanidine Hydrochloride, USP equivalent to 4 mg of Tizanidine base. It is important to keep this medication out of reach of children and store it at 25°C (77°F). The usual dosage information can be accessed by scanning the Package Insert QR Code. Dispensing should be done in a tight, light-resistant container with a child-resistant closure. It is noted that Tizanidine Tablets are not interchangeable with Tizanidine Capsules. This medication is presented in a package containing 90 Tablets. The product has been repackaged by Bryant Ranch Prepack, Inc. and manufactured by ALKALOIDA Chemical Company Zrt.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
